442
Views
79
CrossRef citations to date
0
Altmetric
Review

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence

, , , , &
Pages 55-64 | Published online: 24 Feb 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Aye Moa, Mohana Kunasekaran, Zubair Akhtar, Valentina Costantino & C. Raina MacIntyre. (2023) Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities. Human Vaccines & Immunotherapeutics 19:3.
Read now
Thach H. Chu, Edward F. Patz$suffix/text()$suffix/text() & Margaret E. Ackerman. (2021) Coming together at the hinges: Therapeutic prospects of IgG3. mAbs 13:1.
Read now
Qi Hao Looi, Jhi Biau Foo, May Teng Lim, Cheng Foh Le & Pau Loke Show. (2018) How far have we reached in development of effective influenza vaccine?. International Reviews of Immunology 37:5, pages 266-276.
Read now
Eduardo de Gomensoro, Giuseppe Del Giudice & T. Mark Doherty. (2018) Challenges in adult vaccination. Annals of Medicine 50:3, pages 181-192.
Read now
María Morales Suárez-Varela, Agustin Llopis, Estrella Fernandez-Fabrellas, Francisco Sanz, M. Jose Perez-Lozano, Vicente Martin, Jenaro Astray, Jesús Castilla, Mikel Egurrola, Luis Force, Diana Toledo & Àngela Domínguez. (2018) Asthma and influenza vaccination in elderly hospitalized patients: Matched case-control study in Spain. Journal of Asthma 55:4, pages 391-401.
Read now
Richard Aspinall & Pierre Olivier Lang. (2018) Vaccination choices for older people, looking beyond age specific approaches. Expert Review of Vaccines 17:1, pages 23-30.
Read now
Sai V Vemula, Ekramy E Sayedahmed, Suryaprakash Sambhara & Suresh K Mittal. (2017) Vaccine approaches conferring cross-protection against influenza viruses. Expert Review of Vaccines 16:11, pages 1141-1154.
Read now
Dessi Loukov, Avee Naidoo & Dawn ME Bowdish. (2015) Immunosenescence: implications for vaccination programs in the elderly. Vaccine: Development and Therapy 5, pages 17-29.
Read now

Articles from other publishers (70)

Yenisey Triana Marrero, Vianed Marsán Suárez, Consuelo Milagros Macías Abraham, Imilla Casado Hernández, Elizabeth Hernández Ramos, Gabriela Díaz Domínguez, Yaneisy Duarte Pérez, Mary Carmen Reyes Zamora, Ana María Simón Pita & Luis Felipe Heredia Guerra. (2023) Peripheral double negative T: A look at senescent Cubans. Experimental Gerontology 171, pages 112006.
Crossref
Peggy Riese, Stephanie Trittel, Manas K. Akmatov, Marcus May, Jana Prokein, Thomas Illig, Christoph Schindler, Birgit Sawitzki, Yassin Elfaki, Stefan Floess, Jochen Huehn, Adrian J. Błażejewski, Till Strowig, Esteban A. Hernandez-Vargas, Robert Geffers, Bowen Zhang, Yang Li, Frank Pessler & Carlos A. Guzmán. (2022) Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly. Nature Communications 13:1.
Crossref
Alper Cevirgel, Sudarshan A. Shetty, Martijn Vos, Nening M. Nanlohy, Lisa Beckers, Elske Bijvank, Nynke Rots, Josine van Beek, Anne‐Marie Buisman & Debbie van Baarle. (2022) Identification of aging‐associated immunotypes and immune stability as indicators of post‐vaccination immune activation. Aging Cell 21:10.
Crossref
Rodney P. Jones & Andrey Ponomarenko. (2022) Roles for Pathogen Interference in Influenza Vaccination, with Implications to Vaccine Effectiveness (VE) and Attribution of Influenza Deaths. Infectious Disease Reports 14:5, pages 710-758.
Crossref
Marie I. Samanovic, Amber R. CorneliusSophie L. Gray-Gaillard, Joseph Richard Allen, Trishala Karmacharya, Jimmy P. Wilson, Sara Wesley HymanMichael TuenSergei B. Koralov, Mark J. Mulligan & Ramin Sedaghat Herati. (2022) Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals. Science Translational Medicine 14:631.
Crossref
YasminH. H. Hussein, MonaH Ibrahim, ShahendaG Badran & SehamM Eldeeb. (2022) Hesitancy for influenza vaccine among healthcare workers and mothers of preschool children: A cross-sectional study in Zagazig, Egypt. Journal of Family and Community Medicine 29:2, pages 108.
Crossref
N. V. Orlova & V. V. Lomaychikov. (2021) Role of etiotropic therapy in the treatment and prevention of influenza complications amidst the COVID-19 pandemic. Meditsinskiy sovet = Medical Council:18, pages 86-93.
Crossref
Yi Hu, Yusi Liu, Yibing Yin & Xuemei Zhang. (2021) Protective efficacy of mucosal and subcutaneous immunization with DnaJ-ΔA146Ply against influenza and Streptococcus pneumoniae co-infection in mice. Microbes and Infection 23:8, pages 104813.
Crossref
Mei Peng Tan, Wen Siang Tan, Noorjahan Banu Mohamed Alitheen & Wei Boon Yap. (2021) M2e-Based Influenza Vaccines with Nucleoprotein: A Review. Vaccines 9:7, pages 739.
Crossref
Kristen D. Popowski, Phuong‐Uyen C. Dinh, Arianna George, Halle Lutz & Ke Cheng. (2021) Exosome therapeutics for COVID‐19 and respiratory viruses. VIEW 2:3, pages 20200186.
Crossref
Genieve Ee Chia Yeo, Min Hwei Ng, Fazlina Binti Nordin & Jia Xian Law. (2021) Potential of Mesenchymal Stem Cells in the Rejuvenation of the Aging Immune System. International Journal of Molecular Sciences 22:11, pages 5749.
Crossref
Ramin Sedaghat Herati, Luisa Victoria Silva, Laura A. Vella, Alexander Muselman, Cecile Alanio, Bertram Bengsch, Raj K. Kurupati, Senthil Kannan, Sasikanth Manne, Andrew V. Kossenkov, David H. Canaday, Susan A. Doyle, Hildegund C.J. Ertl, Kenneth E. Schmader & E. John Wherry. (2021) Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways. Cell Reports Medicine 2:5, pages 100262.
Crossref
Vinciane Saint-Criq, Geanncarlo Lugo-Villarino & Muriel Thomas. (2021) Dysbiosis, malnutrition and enhanced gut-lung axis contribute to age-related respiratory diseases. Ageing Research Reviews 66, pages 101235.
Crossref
I. A. Leneva, I. N. Falynskova, N. P. Kartashova, E. A. Glubokova, A. V. Poddubikov & O. A. Svitich. (2021) The study of neuraminidase immunity in protection against secondary bacterial pneumonia induced by <i>S. aureus</i> after influenza infection in mice. Journal of microbiology, epidemiology and immunobiology 97:6, pages 564-577.
Crossref
Kenzie Latham-Mintus, Ashley Vowels & Swapnali Chavan. (2020) Neighborhood Disorder, Social Ties, and Preventive Healthcare Utilization among Urban-Dwelling Older Adults. Journal of Aging and Health 32:10, pages 1387-1398.
Crossref
Asos Mahmood, Hyunmin Kim, Umar Kabir, Satish Kedia & Meredith Ray. (2020) Food Insecurity and Influenza and Pneumonia Vaccines Uptake Among Community-Dwelling Older Adults in the United States. Journal of Community Health 45:5, pages 943-953.
Crossref
Weili Xu, Glenn Wong, You Yi Hwang & Anis Larbi. (2020) The untwining of immunosenescence and aging. Seminars in Immunopathology 42:5, pages 559-572.
Crossref
Debbie Van Baarle, Kaatje Bollaerts, Giuseppe Del Giudice, Stephen Lockhart, Christine Luxemburger, Maarten J. Postma, Aura Timen & Baudouin Standaert. (2020) Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project. Vaccine 38:37, pages 5896-5904.
Crossref
Weili Xu, Zandrea Wan Xuan Lau, Tamas Fulop & Anis Larbi. (2020) The Aging of γδ T Cells. Cells 9:5, pages 1181.
Crossref
Christopher L. Cummings, Wei Yi Kong & Jeanette Orminski. (2020) A typology of beliefs and misperceptions about the influenza disease and vaccine among older adults in Singapore. PLOS ONE 15:5, pages e0232472.
Crossref
Mu Yue, Borame L. Dickens, Joanne Su-yin Yoong, Mark I-Cheng Chen, Yot Teerawattananon & Alex R. Cook. (2019) Cost-Effectiveness Analysis for Influenza Vaccination Coverage and Timing in Tropical and Subtropical Climate Settings: A Modeling Study. Value in Health 22:12, pages 1345-1354.
Crossref
L.M. Teo, H.E. Smith, M.O. Lwin & W.E. Tang. (2019) Attitudes and perception of influenza vaccines among older people in Singapore: A qualitative study. Vaccine 37:44, pages 6665-6672.
Crossref
Candice A. Smith, Daniel J. Tyrell, Upasana A. Kulkarni, Sherri Wood, Lin Leng, Rachel L. Zemans, Richard Bucala & Daniel R. Goldstein. (2019) Macrophage migration inhibitory factor enhances influenza-associated mortality in mice. JCI Insight 4:13.
Crossref
Roqayeh Aliyari, Shakiba Imani, Tooba Rezaiy, Mohammad Shariati, Parastoo Hanifehzad Masooleh & Seyed Mohammad Mirrezaie. (2019) Seasonal Influenza Vaccination Uptake and Its Socioeconomic Determinants in Patients and Staff of Hospitals in Shahroud, Northwest of Iran. Shiraz E-Medical Journal In Press:In Press.
Crossref
Abdinasir Abubakar, Nada Melhem, Mamunur Malik, Ghassan Dbaibo, Wasiq Mehmood Khan & Hassan Zaraket. (2019) Seasonal influenza vaccination policies in the Eastern Mediterranean Region: Current status and the way forward. Vaccine 37:12, pages 1601-1607.
Crossref
Savita Nair & Luis J. Sigal. 2019. Handbook of Immunosenescence. Handbook of Immunosenescence 967 979 .
Savita Nair & Luis J. Sigal. 2020. Handbook of Immunosenescence. Handbook of Immunosenescence 1 13 .
Richard Aspinall & Pierre Olivier Lang. (2018) Interventions to restore appropriate immune function in the elderly. Immunity & Ageing 15:1.
Crossref
Luis Beck da Silva & Luis Eduardo Rohde. (2018) Vaccinations in Heart Failure. JACC: Heart Failure 6:10, pages 856-858.
Crossref
Suchitra S. Prabhu, Trirupa Tapas Chakraborty, Nirmal Kumar & Indranil Banerjee. (2018) Association between IFITM3 rs12252 polymorphism and influenza susceptibility and severity: A meta-analysis. Gene 674, pages 70-79.
Crossref
Richard G Pebody, Fiona Warburton, Nick Andrews, Mary Sinnathamby, Ivelina Yonova, Arlene Reynolds, Chris Robertson, Simon Cottrell, Muhammad Sartaj, Rory Gunson, Matthew Donati, Catherine Moore, Joanna Ellis, Simon de Lusignan, Jim McMenamin & Maria Zambon. (2018) Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17. Eurosurveillance 23:39.
Crossref
Sonia Jain, Parakkal Jovvian George, Wanyan Deng, Joseph Koussa, Kaela Parkhouse, Scott E. Hensley, Jiu Jiang, Jie Lu, Zhuyun Liu, Junfei Wei, Bin Zhan, Maria Elena Bottazzi, Hao Shen & Sara Lustigman. (2018) The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4 + T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway. Vaccine 36:25, pages 3650-3665.
Crossref
Erica Y. Tong, Biswadev Mitra, Cristina P. Roman, Gary Yip, Suzanne Olding, Carolyn Joyce, Kirstie Galbraith & Michael J. Dooley. (2018) Improving influenza vaccination among hospitalised patients in General Medicine and Emergency Short Stay units – a pharmacist‐led approach. Journal of Pharmacy Practice and Research 48:3, pages 231-235.
Crossref
Halil KAZANASMAZ, Süleyman GETER, Abdullah SOLMAZ, Şakir GENÇ & Hüseyin GÜMÜŞ. (2018) Epidemik Dönemde Şanlıurfa İli Pandemik H1N1 İnfluenza Olgularının Klinik DeğerlendirmesiClinical Evaluation of Cases of Pandemic H1N1 Influenza in Sanliurfa Province in Epidemic Period. Acta Medica Alanya 2:1, pages 14-19.
Crossref
William Trim, James E. Turner & Dylan Thompson. (2018) Parallels in Immunometabolic Adipose Tissue Dysfunction with Ageing and Obesity. Frontiers in Immunology 9.
Crossref
Emily A. Voigt, Diane E. Grill, Michael T. Zimmermann, Whitney L. Simon, Inna G. Ovsyannikova, Richard B. Kennedy & Gregory A. Poland. (2018) Transcriptomic signatures of cellular and humoral immune responses in older adults after seasonal influenza vaccination identified by data-driven clustering. Scientific Reports 8:1.
Crossref
Jung Keun ParkSoo LeeJi Eun LeeKyung-Do HanJi Hyun KimJin Hee YoonSuk Won ParkYang-Hyun Kim & Kyung-Hwan Cho. (2018) The Association between Smoking Status and Influenza Vaccination Coverage Rate in Korean Adults: Analysis of the 2010–2012 Korea National Health and Nutrition Examination Survey. Korean Journal of Family Medicine 39:2, pages 90.
Crossref
Jean-Marie Robine. (2017) When climate change encounters the revolution in adult longevity. Aging Clinical and Experimental Research 29:6, pages 1073-1074.
Crossref
P. N. ZIVICH, L. TATHAM, K. LUNG, J. TIEN, C. E. BOLLINGER & J. K. BOWER. (2017) Influenza vaccination status and outcomes among influenza-associated hospitalizations in Columbus, Ohio (2012–2015). Epidemiology and Infection 145:15, pages 3284-3293.
Crossref
Carl E Koppeschaar, Vittoria Colizza, Caroline Guerrisi, Clément Turbelin, Jim Duggan, W John Edmunds, Charlotte Kjelsø, Ricardo Mexia, Yamir Moreno, Sandro Meloni, Daniela Paolotti, Daniela Perrotta, Edward van Straten & Ana O Franco. (2017) Influenzanet: Citizens Among 10 Countries Collaborating to Monitor Influenza in Europe. JMIR Public Health and Surveillance 3:3, pages e66.
Crossref
Deborah Louise Duncan. (2017) Immunisation in the elderly. Nurse Prescribing 15:9, pages 438-444.
Crossref
Peggy Riese & Carlos A. Guzmán. (2017) Roads to advanced vaccines: influenza case study. Microbial Biotechnology 10:5, pages 1036-1040.
Crossref
Angela Domínguez, Núria Soldevila, Diana Toledo, Pere Godoy, Elena Espejo, Maria Amelia Fernandez, José María Mayoral, Jesús Castilla, Mikel Egurrola, Sonia Tamames, Jenaro Astray & María Morales-Suárez-Varela. (2017) The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: a multicentre case–control study, Spain, 2013/14 and 2014/15. Eurosurveillance 22:34.
Crossref
Weili Xu & Anis Larbi. (2017) Markers of T Cell Senescence in Humans. International Journal of Molecular Sciences 18:8, pages 1742.
Crossref
Jacqueline U. McDonald, Ziyun Zhong, Helen T. Groves & John S. Tregoning. (2017) Inflammatory responses to influenza vaccination at the extremes of age. Immunology 151:4, pages 451-463.
Crossref
L. W. ANG, J. CUTTER, L. JAMES & K. T. GOH. (2016) Factors associated with influenza vaccine uptake in older adults living in the community in Singapore. Epidemiology and Infection 145:4, pages 775-786.
Crossref
Clementine S. Fraser, Akhilesh Jha & Peter J.M. Openshaw. (2017) Vaccines in the Prevention of Viral Pneumonia. Clinics in Chest Medicine 38:1, pages 155-169.
Crossref
Po-Po Lam, Brenda L. Coleman, Karen Green, Jeff Powis, David Richardson, Kevin Katz, Bjug Borgundvaag, Telisha Smith-Gorvie, Jeffrey C. Kwong, Susan J. Bondy & Allison McGeer. (2016) Predictors of influenza among older adults in the emergency department. BMC Infectious Diseases 16:1.
Crossref
E. Contal, A. Putot, M. Dipanda, S. Perrin, S. Asgassou, H. Sordet-Guépet & P. Manckoundia. (2016) La couverture vaccinale contre la grippe saisonnière du personnel soignant en gériatrie : mise au point. Revue d'Épidémiologie et de Santé Publique 64:6, pages 415-423.
Crossref
Jiu Jiang, Erin M. Fisher, Mark Concannon, Sara Lustigman, Hao Shen & Donna M. Murasko. (2016) Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, r Ov -ASP-1. Vaccine 34:7, pages 887-892.
Crossref
Maartje Kristensen, Alies van Lier, Renske Eilers, Scott A. McDonald, Wim Opstelten, Nicoline van der Maas, Wim van der Hoek, Mirjam E. Kretzschmar, Mark M. Nielen & Hester E. de Melker. (2016) Burden of four vaccine preventable diseases in older adults. Vaccine 34:7, pages 942-949.
Crossref
Alessandro Boianelli, Van Nguyen, Thomas Ebensen, Kai Schulze, Esther Wilk, Niharika Sharma, Sabine Stegemann-Koniszewski, Dunja Bruder, Franklin Toapanta, Carlos Guzmán, Michael Meyer-Hermann & Esteban Hernandez-Vargas. (2015) Modeling Influenza Virus Infection: A Roadmap for Influenza Research. Viruses 7:10, pages 5274-5304.
Crossref
Iana H. Haralambieva, Scott D. Painter, Richard B. Kennedy, Inna G. Ovsyannikova, Nathaniel D. Lambert, Krista M. Goergen, Ann L. Oberg & Gregory A. Poland. (2015) The Impact of Immunosenescence on Humoral Immune Response Variation after Influenza A/H1N1 Vaccination in Older Subjects. PLOS ONE 10:3, pages e0122282.
Crossref
Kyu-Chong Lee, Kyungdo Han, Jin Yong Kim, Ga Eun Nam, Byoung-Duck Han, Koh-Eun Shin, Anna Lee & Byung Joon Ko. (2015) Socioeconomic Status and Other Related Factors of Seasonal Influenza Vaccination in the South Korean Adult Population Based on a Nationwide Cross-Sectional Study. PLOS ONE 10:2, pages e0117305.
Crossref
Li Wei Ang, Cindy Lim, Vernon Jian Ming Lee, Stefan Ma, Wei Wei Tiong, Peng Lim Ooi, Raymond Tzer Pin Lin, Lyn James & Jeffery Cutter. (2014) Influenza-Associated Hospitalizations, Singapore, 2004–2008 and 2010–2012. Emerging Infectious Diseases 20:10, pages 1652-1660.
Crossref
Pierre-Olivier Lang & Richard Aspinall. (2014) Vaccination in the Elderly: What Can Be Recommended?. Drugs & Aging 31:8, pages 581-599.
Crossref
Jiu Jiang, Erin M. Fisher, Scott E. Hensley, Sara Lustigman, Donna M. Murasko & Hao Shen. (2014) Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines. Vaccine 32:23, pages 2696-2702.
Crossref
Peter Tsang, Geoffrey J. Gorse, Cynthia B. Strout, Malcolm Sperling, David P. Greenberg, Ayca Ozol-Godfrey, Carlos DiazGranados & Victoria Landolfi. (2014) Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial. Vaccine 32:21, pages 2507-2517.
Crossref
Scott D. PainterIana H. HaralambievaInna G. OvsyannikovaDiane E. GrillGregory A. Poland. (2014) Detection of Influenza A/H1N1-Specific Human IgG-Secreting B Cells in Older Adults by ELISPOT Assay. Viral Immunology 27:2, pages 32-38.
Crossref
Pierre-Olivier Lang. (2013) Why Influenza Viruses Continue to Pose a Significant Threat to Aging and Aged Populations Worldwide. Current Geriatrics Reports 3:1, pages 56-65.
Crossref
Ie-Bin Lian, Hong-Dar Isaac Wu, Wan-Tzu Chang & Day-Yu Chao. (2014) The Temporal Trend of Influenza-Associated Morbidity and the Impact of Early Appearance of Antigenic Drifted Strains in a Southeast Asian Country. PLoS ONE 9:1, pages e84239.
Crossref
М.К. Erofeeva, I.J. Nickonorov, V.L. Maksakova, M.A. Stukova, O.S. Konshina, E.A. Okhapkina, E.M. Voicehovskaya, S.A. Korovkin, S.J. Melnikhov & O.I. Kiselev. (2014) Protective Properties of Inactivated Virosomal Influenza Vaccine. Procedia in Vaccinology 8, pages 24-33.
Crossref
Annemieke M. H. Boots, Andrea B. Maier, Piet Stinissen, Pierre Masson, Rik J. Lories & Filip De Keyser. (2013) The influence of ageing on the development and management of rheumatoid arthritis. Nature Reviews Rheumatology 9:10, pages 604-613.
Crossref
Pierre Olivier Lang, Sheila Govind & Richard Aspinall. (2012) Reversing T cell immunosenescence: why, who, and how. AGE 35:3, pages 609-620.
Crossref
P.O. Lang, D. Samaras & N. Samaras. (2013) Does vitamin D deficiency contribute to further impinge the state of vulnerability to infections of aging and aged adults?. European Geriatric Medicine 4:1, pages 59-65.
Crossref
Ljiljana Trtica-Majnaric. (2013) Improving Influenza Vaccination Rates— A Straightforward Task or a Multifaceted Challenge?. World Journal of Vaccines 03:02, pages 60-67.
Crossref
Anton Kutikhin, Elena Brusina & Arseniy E. YuzhalinAnton Kutikhin, Elena Brusina & Arseniy E. Yuzhalin. 2013. Viruses and Atherosclerosis. Viruses and Atherosclerosis 65 67 .
P.-O. Lang, S. Govind & R. Aspinall. (2012) Efficacité des vaccins antigrippes chez la personne âgée. NPG Neurologie - Psychiatrie - Gériatrie 12:69, pages 121-130.
Crossref
P.O. Lang & J.-P. Michel. (2012) Se faire vacciner après 60 ans : pourquoi et comment ?. NPG Neurologie - Psychiatrie - Gériatrie 12:69, pages 103-110.
Crossref
Lidia B. Brydak, Agnieszka Woźniak Kosek & Aneta Nitsch-Osuch. (2012) Influenza vaccines and vaccinations in Poland – past, present and future. Medical Science Monitor 18:11, pages RA166-RA171.
Crossref